{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:46:50Z","timestamp":1784958410528,"version":"3.55.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/europace\/euw384","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T12:07:01Z","timestamp":1478088421000},"page":"1637-1642","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study)"],"prefix":"10.1093","volume":"19","author":[{"given":"Aleksander","family":"Maciag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal M","family":"Farkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Chwyczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Beckowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Syska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Kowalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Pytkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Szwed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,22]]},"reference":[{"key":"key\n\t\t\t\t20171014031002_euw384-B1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"14","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171014031002_euw384-B2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171014031002_euw384-B3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.amjcard.2010.06.054","article-title":"Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation","volume":"106","year":"2010","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171014031002_euw384-B4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial","volume":"117","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171014031002_euw384-B5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ahj.2010.02.035","article-title":"A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm","volume":"159","year":"2010","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171014031002_euw384-B6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-9149(62)90075-9","article-title":"Evaluation of the antiarrhythmic properties of antazoline. A preliminary study","volume":"9","year":"1962","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171014031002_euw384-B7","first-page":"113","article-title":"The action of the antihistaminic agents antazoline and meclizine on experimental arrhythmias","volume":"22","year":"1967","journal-title":"Acta Cardiol"},{"key":"key\n\t\t\t\t20171014031002_euw384-B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/000331977002100104","article-title":"Conversion of atrial fibrillation with antazoline hydrochloride (Arithmin)","volume":"21","year":"1970","journal-title":"Angiology"},{"key":"key\n\t\t\t\t20171014031002_euw384-B9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/bmc.2965","article-title":"Determination of antazoline hydrochloride in rat plasma and excreta by reversed-phase ion-pair chromatography and its application to pharmacokinetics","volume":"27","year":"2013","journal-title":"Biomed Chromatogr"},{"key":"key\n\t\t\t\t20171014031002_euw384-B10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-8703(63)90123-6","article-title":"Clinical and physiologic effects of antazoline, a new antiarrhythmic agent","volume":"65","year":"1963","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171014031002_euw384-B11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpba.2016.01.060","article-title":"Application of a novel liquid chromatography\/tandem mass spectrometry method for the determination of antazoline in human plasma: result of ELEPHANT-I [ELEctrophysiological, pharmacokinetic and hemodynamic effects of PHenazolinum (ANTazoline mesylate)] human pharmacokinetic study","volume":"123","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"key\n\t\t\t\t20171014031002_euw384-B12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9149(63)90084-5","article-title":"A clinical evaluation of the antiarrhythmic properties of antazoline","volume":"11","year":"1963","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171014031002_euw384-B13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9149(64)90035-9","article-title":"A clinical trial of antazoline in the treatment of arrhythmias","volume":"14","year":"1964","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171014031002_euw384-B14","first-page":"924","article-title":"Evaluation of the anti-arrhythmia effectiveness of Phenazolinum Polfa in paroxysmal atrial fibrillation","volume":"45","year":"1990","journal-title":"Pol Tyg Lek"},{"key":"key\n\t\t\t\t20171014031002_euw384-B15","first-page":"247","article-title":"Antazoline \u2013 ineffective or misprized in the treatment of paroxysmal atrial fibrillation?","volume":"3","year":"2000","journal-title":"Pol J Cardiol"},{"key":"key\n\t\t\t\t20171014031002_euw384-B16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.advms.2015.03.002","article-title":"Antazoline for termination of atrial fibrillation during the procedure of pulmonary veins isolation","volume":"60","year":"2015","journal-title":"Adv Med Sci"},{"key":"key\n\t\t\t\t20171014031002_euw384-B17","article-title":"Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation \u2013 a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)","volume":"13","year":"2012","journal-title":"Trials"},{"key":"key\n\t\t\t\t20171014031002_euw384-B18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MEJ.0000000000000198","article-title":"The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department","volume":"22","author":"Emergency Medicine Research Group, Edinburgh (EMERGE)","year":"2015","journal-title":"Eur J Emerg Med"},{"key":"key\n\t\t\t\t20171014031002_euw384-B19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/acem.12016","article-title":"An international view of how recent-onset atrial fibrillation is treated in the emergency department","volume":"19","year":"2012","journal-title":"Acad Emerg Med"},{"key":"key\n\t\t\t\t20171014031002_euw384-B20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/europace\/eut274","article-title":"Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines","volume":"16","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171014031002_euw384-B21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/europace\/eut143","article-title":"Cardioversion for atrial fibrillation in current European practice: results of the European heart rhythm association survey","volume":"15","year":"2013","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171014031002_euw384-B22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5603\/CJ.a2013.0121","article-title":"Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways","volume":"21","year":"2014","journal-title":"Cardiol J"},{"key":"key\n\t\t\t\t20171014031002_euw384-B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.20452\/pamw.3452","article-title":"Comparative effectiveness and safety of antazoline-based and propafenone-based strategies for pharmacological cardioversion of short-duration atrial fibrillation in the emergency department","volume":"126","year":"2016","journal-title":"Pol Arch Med Wewn"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/19\/10\/1637\/20917258\/euw384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:21:47Z","timestamp":1749684107000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/europace\/article\/19\/10\/1637\/2736329\/Efficacy-and-safety-of-antazoline-in-the-rapid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,22]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,12,22]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw384","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2016,12,22]]}}}